1. Evaluation and optimization of treatment for patients with metastatic breast cancer and receiving CDK4/6-inhibitors. (November 2022) Authors: Henze, F.; Hester, A.; Koenig, A.; Harbeck, N.; Wuerstlein, R. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Interaction of PAFAH and beta-catenin in BRCA1 mutant breast cancer. (October 2020) Authors: Liao, Y.; Mayr, D.; Schmoeckel, E.; Hester, A.; Kolben, T.; Zeder-Göß, C.; Würstlein, R.; Harbeck, N.; Mahner, S.; Jeschke, U.; Trillsch, F.; Czogalla, B. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗